Literature DB >> 30281324

Elastase Exocytosis by Airway Neutrophils Is Associated with Early Lung Damage in Children with Cystic Fibrosis.

Camilla Margaroli1,2, Luke W Garratt3, Hamed Horati4, A Susanne Dittrich5,6, Timothy Rosenow3, Samuel T Montgomery3, Dario L Frey5, Milton R Brown1,2, Carsten Schultz7, Lokesh Guglani1,2, Anthony Kicic3,8,9, Limin Peng10, Bob J Scholte4, Marcus A Mall5,11,12, Hettie M Janssens4, Stephen M Stick3,8,9, Rabindra Tirouvanziam1,2.   

Abstract

RATIONALE: Neutrophils are recruited to the airways of individuals with cystic fibrosis (CF). In adolescents and adults with CF, airway neutrophils actively exocytose the primary granule protease elastase (NE), whose extracellular activity correlates with lung damage. During childhood, free extracellular NE activity is measurable only in a subset of patients, and the exocytic function of airway neutrophils is unknown.
OBJECTIVES: To measure NE exocytosis by airway neutrophils in relation to free extracellular NE activity and lung damage in children with CF.
METHODS: We measured lung damage using chest computed tomography coupled with the Perth-Rotterdam Annotated Grid Morphometric Analysis for Cystic Fibrosis scoring system. Concomitantly, we phenotyped blood and BAL fluid leukocytes by flow and image cytometry, and measured free extracellular NE activity using spectrophotometric and Förster resonance energy transfer assays. Children with airway inflammation linked to aerodigestive disorder were enrolled as control subjects.
MEASUREMENTS AND MAIN RESULTS: Children with CF but not disease control children harbored BAL fluid neutrophils with high exocytosis of primary granules, before the detection of bronchiectasis. This measure of NE exocytosis correlated with lung damage (R = 0.55; P = 0.0008), whereas the molecular measure of free extracellular NE activity did not. This discrepancy may be caused by the inhibition of extracellular NE by BAL fluid antiproteases and its binding to leukocytes.
CONCLUSIONS: NE exocytosis by airway neutrophils occurs in all children with CF, and its cellular measure correlates with early lung damage. These findings implicate live airway neutrophils in early CF pathogenesis, which should instruct biomarker development and antiinflammatory therapy in children with CF.

Entities:  

Keywords:  air trapping; degranulation; mucus plugging; proteolysis; scavenging

Mesh:

Substances:

Year:  2019        PMID: 30281324      PMCID: PMC6444666          DOI: 10.1164/rccm.201803-0442OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  58 in total

1.  Infection, inflammation, and lung function decline in infants with cystic fibrosis.

Authors:  Naveen Pillarisetti; Elizabeth Williamson; Barry Linnane; Billy Skoric; Colin F Robertson; Phil Robinson; John Massie; Graham L Hall; Peter Sly; Stephen Stick; Sarath Ranganathan
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.

Authors:  David S Armstrong; Sarah M Hook; Kris M Jamsen; Gillian M Nixon; Rosemary Carzino; John B Carlin; Colin F Robertson; Keith Grimwood
Journal:  Pediatr Pulmonol       Date:  2005-12

3.  Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis.

Authors:  Charles R Esther; Lidija Turkovic; Tim Rosenow; Marianne S Muhlebach; Richard C Boucher; Sarath Ranganathan; Stephen M Stick
Journal:  Eur Respir J       Date:  2016-11-11       Impact factor: 16.671

4.  Early lung disease in young children with primary ciliary dyskinesia.

Authors:  David E Brown; Jessica E Pittman; Margaret W Leigh; Lynn Fordham; Stephanie D Davis
Journal:  Pediatr Pulmonol       Date:  2008-05

5.  Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

Authors:  Scott D Sagel; Ronald L Gibson; Julia Emerson; Sharon McNamara; Jane L Burns; Jeffrey S Wagener; Bonnie W Ramsey
Journal:  J Pediatr       Date:  2008-09-25       Impact factor: 4.406

Review 6.  Cystic fibrosis in young children: A review of disease manifestation, progression, and response to early treatment.

Authors:  Donald R VanDevanter; Jennifer S Kahle; Amy K O'Sullivan; Slaven Sikirica; Paul S Hodgkins
Journal:  J Cyst Fibros       Date:  2015-10-09       Impact factor: 5.482

Review 7.  Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management.

Authors:  Margaret Rosenfeld; Bonnie W Ramsey; Ronald L Gibson
Journal:  Curr Opin Pulm Med       Date:  2003-11       Impact factor: 3.155

8.  Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema.

Authors:  Joanna B Trojanek; Amanda Cobos-Correa; Stefanie Diemer; Michael Kormann; Susanne C Schubert; Zhe Zhou-Suckow; Raman Agrawal; Julia Duerr; Claudius J Wagner; Jolanthe Schatterny; Stephanie Hirtz; Olaf Sommerburg; Dominik Hartl; Carsten Schultz; Marcus A Mall
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 9.  Origins of cystic fibrosis lung disease.

Authors:  David A Stoltz; David K Meyerholz; Michael J Welsh
Journal:  N Engl J Med       Date:  2015-01-22       Impact factor: 91.245

Review 10.  Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis.

Authors:  Michael Fayon; Lisa Kent; Stephanie Bui; Lieven Dupont; Isabelle Sermet
Journal:  Eur Respir J       Date:  2013-07-11       Impact factor: 33.795

View more
  16 in total

1.  Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis.

Authors:  Jonas C Schupp; Sara Khanal; Jose L Gomez; Maor Sauler; Taylor S Adams; Geoffrey L Chupp; Xiting Yan; Sergio Poli; Yujiao Zhao; Ruth R Montgomery; Ivan O Rosas; Charles S Dela Cruz; Emanuela M Bruscia; Marie E Egan; Naftali Kaminski; Clemente J Britto
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

Review 2.  Update in Cystic Fibrosis 2018.

Authors:  Bonnie W Ramsey; Gregory P Downey; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

Review 3.  Targeting Proteases in Cystic Fibrosis Lung Disease. Paradigms, Progress, and Potential.

Authors:  Michael C McKelvey; Sinéad Weldon; Daniel F McAuley; Marcus A Mall; Clifford C Taggart
Journal:  Am J Respir Crit Care Med       Date:  2020-01-15       Impact factor: 21.405

Review 4.  Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.

Authors:  Meraj A Khan; Zubair Sabz Ali; Neil Sweezey; Hartmut Grasemann; Nades Palaniyar
Journal:  Genes (Basel)       Date:  2019-02-26       Impact factor: 4.096

5.  N-chlorination mediates protective and immunomodulatory effects of oxidized human plasma proteins.

Authors:  Agnes Ulfig; Anton V Schulz; Alexandra Müller; Natalie Lupilov; Lars I Leichert
Journal:  Elife       Date:  2019-07-12       Impact factor: 8.140

Review 6.  Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity.

Authors:  Daniel R Laucirica; Luke W Garratt; Anthony Kicic
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

Review 7.  A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity.

Authors:  Rebecca Dowey; Ahmed Iqbal; Simon R Heller; Ian Sabroe; Lynne R Prince
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

Review 8.  Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis.

Authors:  Mirjam Stahl; Eva Steinke; Marcus A Mall
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

Review 9.  Immunomodulation in Cystic Fibrosis: Why and How?

Authors:  Vincent D Giacalone; Brian S Dobosh; Amit Gaggar; Rabindra Tirouvanziam; Camilla Margaroli
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

Review 10.  Strategies for measuring airway mucus and mucins.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2019-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.